The future of US psychedelic medicine is carved out by the FDA
The US Food and Drug Administration (FDA) has issued its first comprehensive guidance on how psychedelic drugs should best be studied in clinical trials, signalling a shift toward recognizing the…
Read the full articleYou might also wanna read
Final psychedelics guidance suggests FDA is 'receptive' to helping companies succeed
The agency’s finalized recommendations for clinical testing of psychedelic compounds for mental health could pave the way for companies like
The debate about whether the NHS should use magic mushrooms to treat depression
Many clinical trials to test the use of psychedelic medicines for conditions such as depression have been underway since 2022 - with surpris
While the FDA finalizes how to test drugs it treats like heroin, Mass. eyes psychedelic therapy
FDA finalized new guidance for testing MDMA and psilocybin in trials, days after Massachusetts advanced its own psychedelic therapy pilot.
Editorial: Psychedelics pilot could provide proof of medicinal value
With little fanfare, the House of Representatives last week approved creating a five-year psychedelics pilot program that would allow for th
FDA's Psychedelic Guidance; Mass Shootings and Car Crashes; ADHD Drug Misuse Down
(MedPage Today) -- The FDA finalized clinical guidance for psychedelic drug developers and scheduled a public hearing for September to discu
FDA Fast-Tracks Psychedelic-Based Mental Health Treatments as Aging America Faces Rising Long-Term Care Risk
Federal regulators are accelerating psychedelic-based mental health treatments for serious conditions. Many veterans, researchers, and patie
Comments
Sign in to join the conversation.
No comments yet. Be the first.